MedTrace Logo

The Effects of Pulmonary Rehabilitation in Patients With Non-cystic Fibrosis Bronchiectasis

NCT02883101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-07-05

No results posted yet for this study

Summary

Number of Patients:

Study group - Bronchiectasis that is not attributable to Cystic fibrosis

* Group 1 - Pulmonary Rehabilitation
* Group 2 - Standard care

Sample size - 20 in each arm

Study Design:

* Randomised controlled trial (RCT)

All patients who qualify for the study will undergo a detailed evaluation. Baseline assessment will include the following parameters:

* Anthropometry
* Pulmonary Function Tests and Respiratory muscle strength
* Cardiopulmonary Exercise Testing (CPET)
* Six Minute Walk Test (6MWT)
* Severity of dyspnoea (Dyspnoea scale)
* Limb muscle strength
* Inflammatory markers in the serum - C-reactive protein
* Quality of Life

Patients will then be randomized (using table of random numbers) to either the pulmonary rehabilitation group or the standard arm group. After 8 weeks of pulmonary rehabilitation, patients will again be reassessed by the aforementioned tools.

Conditions

  • Non-cystic Fibrosis Bronchiectasis

Interventions

BEHAVIORAL

Pulmonary Rehabilitation

The Rehabilitation Programme will include the following : i. Patient education ii. Exercise training iii. Ventilator and breathing exercises

Sponsors & Collaborators

  • All India Institute of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-10-31
Completion
2016-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883101 on ClinicalTrials.gov